Last $12.79 USD
Change Today -0.42 / -3.18%
Volume 584.8K
SRPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:51 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William A. Goolsbee

Director, Member of Audit Committee and Member of Compensation Committee, Sarepta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 2 different industries.

See Board Relationships
60$617,040

Background*

Mr. William A. Goolsbee, also known as Will, served as an Executive Vice President of Avail Medical Products Inc. Mr. Goolsbee founded Horizon Medical Inc. and served as its Chief Executive Officer and Chairman from 1987 to 2002. He has 30-year career in the medical device and biopharmaceutical industries. Prior to 1987, his experience included increasingly responsible executive positions with CooperVision Inc. and Cooper Laboratories Inc. He served as the Chairman of ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 857-242-3700
Fax: --

Board Members Memberships*

2007-Present
Director, Member of Audit Committee and Member of Compensation Committee

Education*

BA
University of California, Santa Barbara

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$118,500
Total Calculated Compensation$617,040
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRPT:US $12.79 USD -0.42

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
William A. Carter M.D.Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee
Hemispherx Biopharma, Inc.
$1.0M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.